SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950129-07-000751
Filing Date
2007-02-14
Accepted
2007-02-14 17:13:02
Documents
2
Group Members
AMVESCAP PLCINVESCO PRIVATE CAPITAL INC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G h43493llsc13g.txt SC 13G 9052
2 JOINT FILING AGREEMENT h43493llexv99wa.txt EX-99.A 9620
  Complete submission text file 0000950129-07-000751.txt   21136
Mailing Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG
Business Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG 442076380731
AMVESCAP PLC/LONDON/ (Filed by) CIK: 0000914208 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80136 | Film No.: 07622575
SIC: 2834 Pharmaceutical Preparations